Traders should note concentrated pre-IPO ownership by a Bain Capital-affiliated fund, which may influence future trading patterns post-IPO. Monitor for Form 4 activity or S-1 filings indicating an upcoming public offering.
Price Chart
Executive Summary
Andrew T. Kaplan, a Partner at Bain Capital Investors, LLC, filed a Form 3 disclosing indirect beneficial ownership of 17,857,143 shares of Kailera Therapeutics common stock via his affiliation with BCPE Perseus Investor, LP, which holds Series B Preferred Stock convertible into common stock. Kaplan disclaims beneficial ownership except to the extent of his pecuniary interest.
Key Facts
- Form 3 filing by Andrew T. Kaplan, Partner at Bain Capital Investors, LLC
- Disclosure relates to indirect beneficial ownership of 17,857,143 shares of common stock
- Shares are held through BCPE Perseus Investor, LP, which owns Series B Preferred Stock
- Series B Preferred Stock is convertible into common stock on a 1:1 basis
- Automatic conversion upon Kailera's initial public offering
- Kaplan disclaims beneficial ownership except to the extent of his pecuniary interest
Financial Impact
Indirect holding of 17,857,143 common equivalent shares; no immediate dilution or cash flow impact disclosed
Risk Factors
- Potential for significant future share issuance upon IPO conversion, leading to dilution
- Lack of liquidity or public market data for valuation purposes
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-159757 |
| Document: 0001193125-26-159757-index.html | 0001193125-26-159757 |
| Document: 0001193125-26-159757.txt | 0001193125-26-159757 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 22d ago | 3 | $14.91 $12.92 | ▼ −13.35% | ▼ −12.85% | $10.39 (−30.32%) |
Aug 12, 2026 7w ago | 8-K | $17.97 $17.47 | ▼ −2.78% | ▼ −0.82% | $10.39 (−42.18%) |
Jul 31, 2026 9w ago | Court Ruling | $16.94 $18.66 | ▲ +10.15% | ▲ +6.64% | $10.39 (−38.67%) |
Jul 24, 2026 10w ago | Court Ruling | $17.69 $17.05 | ▼ −3.62% | ▼ −3.99% | $10.39 (−41.27%) |
Jun 5, 2026 16w ago | Press Release | $19.70 $19.67 | ▼ −0.15% | ▼ −2.26% | $10.39 (−47.26%) |
May 26, 2026 18w ago | 8-K | $21.91 $22.38 | ▲ +2.15% | ▲ +1.68% | $10.39 (−52.58%) |
May 26, 2026 18w ago | Press Release | $21.91 $22.59 | ▲ +3.10% | ▲ +1.90% | $10.39 (−52.58%) |
May 13, 2026 20w ago | Press Release | $21.11 $19.62 | ▼ −7.06% | ▼ −5.90% | $10.39 (−50.78%) |
Apr 20, 2026 23w ago | 8-K | $25.22 $23.82 | ▼ −5.55% | ▼ −6.63% | $10.39 (−58.80%) |
Apr 20, 2026 23w ago | Insider Cluster | $24.61 $23.51 | ▼ −4.47% | ▼ −5.38% | $10.39 (−57.78%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access